What percentage of the general population carries Methicillin-resistant Staphylococcus aureus (MRSA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MRSA Carriage Rates in the General Population

The prevalence of MRSA carriage in the general population is approximately 0.8-1.5% of people, while overall Staphylococcus aureus nasal colonization affects about 22-37% of the general population. 1, 2, 3, 4

General Population Carriage Rates

Staphylococcus aureus Colonization

  • Approximately 22-37% of the general population carries Staphylococcus aureus nasally 1
  • National Health and Nutrition Examination Survey (NHANES) 2001-2002 data showed:
    • 31.6% (approximately 86.9 million persons) of the non-institutionalized US population was colonized with S. aureus 2, 3
    • This represents nearly one-third of the US population carrying the organism 2

MRSA Colonization

  • MRSA prevalence among S. aureus isolates was 2.58% 2
  • Overall MRSA carriage in the general population:
    • 0.84% in the US (approximately 2.2 million persons) 2, 3
    • 1.5% in a UK community-based survey 4

Variation by Demographics and Risk Factors

Age-Related Differences

  • Among individuals with S. aureus isolates, those aged 65 years or older had the highest MRSA prevalence (8.28%) 2
  • People younger than 65 years were more likely to carry S. aureus in general, but older adults were more likely to carry MRSA specifically 3

Racial/Ethnic Differences

  • Hispanics had the highest prevalence of colonization with S. aureus but were less likely to have MRSA when colonized 2
  • Persons of black race and those of Mexican birth had lower risk for S. aureus colonization 3
  • Hispanic persons had significantly less risk of MRSA colonization compared to white persons 3

Other Risk Factors for MRSA Carriage

  • Women, persons with diabetes, and those who were in long-term care in the past year were more likely to have MRSA colonization 3
  • Prior history of MRSA infection, recent hospitalization, antibiotic exposure, and comorbidities such as immunosuppression increase the risk 1

Regional Variations

  • In the Asia-Pacific region, countries with the highest community-associated MRSA prevalence were India (16.5%-23.5%), Vietnam (7.9%), and Taiwan (3.5%-3.8%) 5
  • The Netherlands maintains an impressively low prevalence of MRSA (approximately 0.03% of patients) through their "search and destroy" approach 6

High-Risk Subgroups

  • Children aged ≤6 years: 0.5%-40.3% MRSA carriage rate 5
  • Household members of MRSA carriers: 13.0%-26.4% carriage rate 5
  • Healthcare workers: 6.1% MRSA colonization rate 1
  • Emergency department patients: 7.8% MRSA colonization rate 1

Clinical Implications

Understanding MRSA carriage rates is crucial for:

  • Guiding preoperative screening protocols, particularly for high-risk surgeries like cardiac and orthopedic procedures 6
  • Implementing appropriate decolonization strategies for carriers before surgery 6
  • Developing targeted infection control measures in healthcare settings 6

The relatively low prevalence of MRSA in the general population (0.8-1.5%) should not lead to complacency, as more than 2.2 million people in the US alone carry this resistant organism, making vigilance in infection control protocols essential 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.